The experimental treatments in our Swiss MDMA/PTSD study were completed in January 2010. In January 2011, we will collect follow-up data from one remaining subject. The clinical research team is developing standardized data-entry conventions to aid analysis. Most of the data from the study already has been entered into a validated database. Clinical Research Associate Berra Yazar-Klosinski, Ph.D., will travel to Switzerland in February to collect the final data from Clinical Investigator Peter Oehen, M.D. While Berra is in Switzerland, she will close the study and archive the data the same way she archived the data this past month for our U.S. MDMA/PTSD study.
